Blair William & Co. IL raised its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 58.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,641 shares of the scientific and technical instruments company's stock after acquiring an additional 12,461 shares during the period. Blair William & Co. IL's holdings in Cognex were worth $1,067,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the stock. T. Rowe Price Investment Management Inc. lifted its stake in shares of Cognex by 32.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock valued at $181,436,000 after buying an additional 1,474,832 shares during the period. Mackenzie Financial Corp lifted its stake in Cognex by 126.2% during the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after purchasing an additional 2,571,457 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Cognex by 34.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock worth $75,756,000 after purchasing an additional 647,955 shares during the period. Bank of New York Mellon Corp lifted its stake in Cognex by 1.9% during the first quarter. Bank of New York Mellon Corp now owns 2,131,538 shares of the scientific and technical instruments company's stock worth $63,584,000 after purchasing an additional 38,857 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in Cognex by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,507,022 shares of the scientific and technical instruments company's stock worth $44,954,000 after purchasing an additional 79,266 shares during the period. Institutional investors own 88.12% of the company's stock.
Cognex Price Performance
Shares of Cognex stock opened at $45.79 on Thursday. The firm has a market cap of $7.69 billion, a P/E ratio of 64.49 and a beta of 1.50. The firm has a 50 day simple moving average of $44.42 and a 200 day simple moving average of $35.20. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $47.52.
Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.02. The business had revenue of $249.09 million during the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. Cognex's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, sell-side analysts expect that Cognex Corporation will post 0.61 EPS for the current year.
Cognex Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Thursday, August 14th. Cognex's payout ratio is currently 45.07%.
Insider Buying and Selling
In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of Cognex stock in a transaction on Monday, September 8th. The shares were sold at an average price of $45.03, for a total transaction of $90,060.00. Following the completion of the sale, the executive vice president owned 6,582 shares of the company's stock, valued at approximately $296,387.46. The trade was a 23.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.60% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Cognex in a research note on Monday, September 15th. They set a "neutral" rating and a $45.00 price target for the company. DA Davidson raised their price target on shares of Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Needham & Company LLC raised their price target on shares of Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. KeyCorp upgraded shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target for the company in a research note on Friday, August 1st. Finally, The Goldman Sachs Group raised their price objective on shares of Cognex from $36.00 to $40.00 and gave the stock a "sell" rating in a report on Tuesday, September 16th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $44.93.
Read Our Latest Research Report on CGNX
Cognex Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.